Considerations for the selection of disease-modifying treatments in SMA: A case-based discussion

touchPANEL DISCUSSION for touchNEUROLOGY

Listen as three experts in spinal muscular atrophy (SMA) discuss factors influencing treatment decision-making with approved SMA therapies using patient case studies.

The experts

• Prof. Eugenio Mercuri – Policlinico Universitario Agostino Gemelli, Rome, Italy
• Prof. Nathalie Goemans – UZ Leuven, Leuven, Belgium
• Prof. Dr. med. Tim Hagenacker – Essen University Hospital, Essen, Germany

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Biogen and Novartis Gene Therapies. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/selecting-disease-modifying-treatments-in-sma/